Division 1.2.15
United Kingdom
Orthosomycins
| For porcine and poultry species, this MRL relates to skin and fat in natural proportions. | ||||
| Not for use in animals from which eggs are produced for human consumption. | ||||
| For porcine and poultry species, this MRL relates to skin and fat in natural proportions. | ||||
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues |
|---|---|---|---|---|
| Avilamycin | Dichloroisoeverninic acid | Porcine | 50 μg/kg | Muscle |
| 100 μg/kg | Fatf1 | |||
| 300 μg/kg | Liver | |||
| 200 μg/kg | Kidney | |||
| Rabbit | 50 μg/kg | Muscle | ||
| 100 μg/kg | Fat | |||
| 300 μg/kg | Liver | |||
| 200 μg/kg | Kidney | |||
| Poultryf2 | 50 μg/kg | Muscle | ||
| 100 μg/kg | Fatf3 | |||
| 300 μg/kg | Liver | |||
| 200 μg/kg | Kidney | |||
Annotations
Footnotes
- f1
-
For porcine and poultry species, this MRL relates to skin and fat in natural proportions.
- f2
-
Not for use in animals from which eggs are produced for human consumption.
- f3
-
For porcine and poultry species, this MRL relates to skin and fat in natural proportions.